Business

Rocket Doctor AI Reports Strong Operational Momentum in Q2 2026 Driven by U.S. Expansion and Growing Patient Reach

Financial Post · September 1, 2026 at 8:07 a.m.

Quarterly revenue for Q2 2026 was $734,028, representing a 43% year-over-year growth.

Loss per share for Q2, 2026: ($0.07) per share.

Announced further signed in-network contracts and credentialing with major U.S. insura

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

Rocket Doctor AI Reports Strong Operational Momentum in Q2 2026 Driven by U.S. Expansion and Growing Patient Reach

More from Financial Post

Weatherford Completes Acquisition of NCS Multistage

Draganfly Secures Milestone FAA Section 44807 Exemption for Heavy Lift Drone Platform, Unlocking Commercial Operations Over 55 Pounds in U.S. Airspace

Conexeu Sciences Sets September and October 2026 Conference Schedule

Global Water Resources Secures $20 Million of Additional Liquidity Through Private Placement and Expanded Revolving Credit Facility

More in Business

Weatherford Completes Acquisition of NCS Multistage

Draganfly Secures Milestone FAA Section 44807 Exemption for Heavy Lift Drone Platform, Unlocking Commercial Operations Over 55 Pounds in U.S. Airspace

Conexeu Sciences Sets September and October 2026 Conference Schedule

Global Water Resources Secures $20 Million of Additional Liquidity Through Private Placement and Expanded Revolving Credit Facility

Seegnal Reports Second Quarter 2026 Financial Results and Provides Business Update

Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference